PRIME-ROSE: EU project receives 6 million EUR from EU Cancer Mission
PRIME-ROSE - A European precision cancer medicine trial network and implementation initiative funded by the EU Cancer Mission. The project was approved by the European Commission om April 23 2023.
Great to be involved in not one but actually two European sister projects!
Great meeting with European Medicines Agency discussing the PRIME-ROSE and PCM4EU - Personalised Cancer Medicine for all EU citizens projects!
Press release: PRIME-ROSE is now approved by the European Commission
PRIME-ROSE - A European precision cancer medicine trial network and implementation initiative funded by the EU Cancer Mission. The project was approved by the European Commission om April 23 2023.